Managing multidrug-resistant HIV with new treatment options: When is the right time?

This session will be the first in a series of short; virtual scientific webinars addressing specific questions about the treatment of heavily treatment experienced (HTE) patients with multidrug resistance (MDR). Despite a decline in prevalence and coverage over the years; MDR HIV is still an extremely relevant issue for HIV patients and clinicians alike. HTE patients with limited options remaining represent a critical area of unmet need; and must remain the subject of ongoing research; discussion and collaboration in the field of HIV. ViiV Healthcare invites you to join a series of engaging webinars led by global and regional experts in virology and the clinical management of MDR HIV patients. Each webinar will present a unique opportunity to explore a key question related to the HTE HIV population in Europe. There will be a focus on clinical case discussions to target understanding of treatment decisions and pathways for complex patients in clinical practice.